Economists warn of costs if US Medicare covers new obesity drugs
The cost of expanding US Medicare prescription drug coverage to pay for expensive, new obesity medications could be catastrophic, health economists warned in a report published on Saturday (Mar 11). Big-selling diabetes drugs have been repurposed as obesity treatments after demonstrating weight loss of more than 20 per cent inContinue Reading